Foropin
Recombinant Human Follicle-Stimulating Hormone (Follitropin alfa)

Supporting Individualized Fertility Treatment

Foropin is a biosimilar recombinant human follicle-stimulating hormone (r-hFSH), developed by Humer Novin Daroo to support fertility treatments.

Containing follitropin alfa, Foropin is used to stimulate follicular development and support ovarian stimulation in assisted reproductive technologies (ART), including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).

Foropin is presented in a multidose, prefilled injection pen designed for subcutaneous administration, allowing flexible and individualized dosing according to patients' clinical needs and treatment protocols.

Manufacturing Excellence & Quality Assurance

Foropin is manufactured under Good Manufacturing Practice (GMP) conditions, with stringent quality standards applied throughout the production process.
From cell line characterization and stability to controlled upstream and downstream processing, each manufacturing stage is designed to ensure consistent product quality.
Comprehensive quality control encompasses protein identity, purity, structural integrity, biological potency, and batch-to-batch consistency.
Through rigorous process monitoring and analytical quality assessment, Humer Novin Daroo is committed to delivering a reliable, high-quality recombinant biopharmaceutical.